40,850 Colgate-Palmolive Company $CL Shares Acquired by YHB Investment Advisors Inc.

YHB Investment Advisors Inc. raised its stake in Colgate-Palmolive Company (NYSE:CL) by 388.0% during the 3rd quarter, Holdings Channel reports. The fund owned 51,377 shares of the company’s stock after acquiring an additional 40,850 shares during the period. YHB Investment Advisors Inc.’s holdings in Colgate-Palmolive were worth $4,383,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently bought and sold shares of CL. State Street Corp boosted its holdings in shares of Colgate-Palmolive by 97.4% during the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after acquiring an additional 46,476,510 shares during the period. Bank of New York Mellon Corp lifted its holdings in Colgate-Palmolive by 172.5% during the 1st quarter. Bank of New York Mellon Corp now owns 12,521,545 shares of the company’s stock worth $1,067,211,000 after purchasing an additional 7,927,238 shares during the last quarter. Bank of America Corp DE acquired a new stake in Colgate-Palmolive during the 2nd quarter worth approximately $567,483,000. Envestnet Asset Management Inc. boosted its stake in Colgate-Palmolive by 266.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 4,146,337 shares of the company’s stock valued at $380,136,000 after purchasing an additional 3,014,860 shares during the period. Finally, Balyasny Asset Management L.P. acquired a new position in Colgate-Palmolive in the 4th quarter valued at $236,682,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Shares of NYSE CL traded up $0.94 during mid-day trading on Thursday, reaching $88.15. The company had a trading volume of 1,484,614 shares, compared to its average volume of 5,689,970. The firm has a market cap of $70.27 billion, a price-to-earnings ratio of 34.98, a PEG ratio of 4.07 and a beta of 0.33. The business’s 50-day simple moving average is $89.23 and its 200 day simple moving average is $88.75. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The business had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $5.36 billion. During the same quarter in the prior year, the business posted $0.92 earnings per share. Colgate-Palmolive’s revenue was up 4.9% compared to the same quarter last year. On average, research analysts predict that Colgate-Palmolive Company will post 3.87 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 84.13%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on CL shares. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating for the company in a report on Monday, August 3rd. Sanford C. Bernstein restated a “market perform” rating on shares of Colgate-Palmolive in a research note on Thursday, August 13th. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating on the stock in a research report on Monday. Morgan Stanley reissued an “overweight” rating and issued a $104.00 price objective on shares of Colgate-Palmolive in a report on Monday, August 3rd. Finally, UBS Group increased their target price on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the stock a “buy” rating in a research report on Monday, August 3rd. Twelve research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $98.65.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel Wallace sold 161,021 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer directly owned 362,231 shares in the company, valued at $33,296,273.52. This represents a 30.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Panagiotis Tsourapas sold 10,000 shares of the firm’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the sale, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 175,191 shares of company stock worth $16,110,903 over the last three months. Corporate insiders own 0.43% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.